私募股权公司Astorg完成对赛默飞全球微生物业务的收购-动脉网

Astorg completes acquisition of Microbiology business from Thermo Fisher Scientific

D-Pharm 等信源发布 2026-08-13 18:48



可切换为仅中文







Astorg, a leading pan-European private equity firm, announced the successful completion of its acquisition of the global microbiology business from Thermo Fisher Scientific. The business will now operate as an independent company under the leadership of Chief Executive Officer Dirk Bontridder and will launch under a new corporate brand later in 2026..

欧洲领先的私募股权公司Astorg宣布，已成功完成从赛默飞世尔科技收购其全球微生物学业务的交易。该业务将在首席执行官Dirk Bontridder的领导下作为独立公司运营，并将于2026年晚些时候以全新的企业品牌亮相。

The transaction establishes an independent company, with the Microbiology business providing the foundation of a global microbiology diagnostics platform serving the clinical, food safety and pharmaceutical markets.

该交易成立了一家独立公司，以微生物学业务为基础，打造服务于临床、食品安全和制药市场的全球微生物诊断平台。

The investment reflects Astorg's focused healthcare strategy and distinctive approach to complex transactions, combining deep sector expertise, and a strong track record of operational value creation.

此次投资体现了Astorg专注于医疗保健领域的战略，以及其在复杂交易中独具特色的方法，将深厚的行业专业知识与卓越的运营价值创造业绩相结合。

Leica Biosystems to acquire StatLab

徕卡生物系统公司收购StatLab

The acquisition is intended to scale up the use of AI-powered cancer diagnostics in anatomical pathology laboratories

此次收购旨在扩大人工智能辅助癌症诊断在解剖病理实验室中的应用规模。

Read news

阅读新闻

Dirk Bontridder has been appointed Chief Executive Officer to lead the company through its next stage of growth, in partnership with Astorg.

德克·邦特里德已被任命为首席执行官，将与阿斯特格合伙公司携手，引领公司进入下一阶段的成长。

The Microbiology business is a global provider of diagnostic consumables and equipment used in microbiological testing across clinical, food safety, and pharmaceutical applications. The business serves more than 15,000 customers across over 100 countries and employs approximately 2,400 employees across 13 manufacturing and R&D sites around the world..

微生物学业务是全球诊断耗材和设备的供应商，这些产品用于临床、食品安全和制药应用中的微生物检测。该业务服务于超过100个国家的15,000多名客户，并在全球13个制造和研发基地雇佣了约2,400名员工。

Commenting on the completion, Judith Charpentier, Co-Managing Partner and Head of Healthcare at Astorg, said: 'This is precisely the type of complex opportunity where Astorg can make a difference, combining deep healthcare expertise, an entrepreneurial and hands-on partnership model, and a strong track record of value creation across the companies we back.'.

Astorg 的联合管理合伙人兼医疗健康板块负责人朱迪思·夏庞蒂埃（Judith Charpentier）就此次交易的完成评论道：“这正是 Astorg 能够发挥影响力的复杂机遇类型，我们将深厚的医疗健康专业知识、创业型且亲力亲为的合作伙伴模式，以及在所投公司中创造价值的卓越记录相结合。”

Olivier Lieven, Partner at Astorg, added: 'We are delighted to welcome Dirk and look forward to working with him and the management team to deliver the company's next phase of growth, accelerate innovation and strengthen its global position.'

阿斯托格（Astorg）合伙人奥利维耶·利文（Olivier Lieven）补充道：“我们很高兴欢迎德克（Dirk）的加入，并期待与他及管理层团队合作，推动公司进入下一阶段的成长，加速创新，并巩固其全球地位。”

Dirk Bontridder, Chief Executive Officer, concluded: 'This is a unique journey to create an independent global microbiology diagnostics company with an exceptional portfolio, talented teams and a long-standing reputation for quality, scientific excellence and customer service. I look forward to working with colleagues around the world and with Astorg to build on these strengths, continue delivering the products, service and innovation that our customers rely on, and introduce our new brand in due course as we begin this next chapter.'.

首席执行官德克·邦特里德总结道：“这是一段独特的历程，旨在打造一家独立的全球微生物诊断公司，公司拥有卓越的产品组合、才华横溢的团队，以及在质量、科学卓越性和客户服务方面久负盛名的声誉。我期待与全球同事以及阿斯特格（Astorg）携手合作，在这些优势的基础上再接再厉，持续提供客户所信赖的产品、服务与创新，并在我们开启这一新篇章之际，适时推出我们的新品牌。”

Dirk brings more than 25 years of international leadership experience across life sciences, diagnostics and industrial technology. Most recently, he served as Chief Executive Officer of PerkinElmer, where he led the company's transformation into a focused global provider of analytical and laboratory solutions.

德克在生命科学、诊断和工业技术领域拥有超过25年的国际领导经验。最近，他担任珀金埃尔默公司首席执行官，带领公司转型为专注于提供分析和实验室解决方案的全球供应商。

He previously served as Chief Executive Officer of Reynaers Group and as Group Executive Vice President BioPharma Services & Clinical Diagnostics at Eurofins Scientific, one of the world's leading life sciences companies. Dirk began his career as a management consultant at McKinsey & Company..

他此前曾担任 Reynaers Group 的首席执行官，并在全球领先的生命科学公司之一 Eurofins Scientific 担任集团执行副总裁，负责生物制药服务与临床诊断业务。Dirk 的职业生涯始于麦肯锡公司，担任管理顾问。

https://www.bionity.com/en/news/1189585/astorg-completes-acquisition-of-microbiology-business-from-thermo-fisher-scientific.html

Roche acquires PathAI to transform AI-driven diagnostics

罗氏收购PathAI，以变革人工智能驱动的诊断技术

This acquisition strengthens Roche’s position in digital pathology

此次收购巩固了罗氏在数字病理学领域的地位

Read news

阅读新闻